$DIN

Dine Brands Global, Inc. Q2 2026 Earnings Call Summary

Dine Brands Global (Applebee’s, IHOP) reported Q2 2026 call updates: management cited intentional consumer spending amid inflation and maintained full-year guidance. Applebee’s saw sequential improvement after a weak April, with remodels lifting mid-single-digit sales. IHOP beat traffic benchmarks for a third quarter. Adjusted FCF fell to $3.7M in H1; $100M buyback authorized.

Original reporting
Published Aug 7, 2026, 12:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 1:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Dine Brands Global, Inc. Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$DINBullishMed
01

Why it matters

Traders can update expectations for unit-level profitability and cash flow trajectory based on remodel-driven sales lift, delivery/catering growth, and the company-owned portfolio turnaround plan, alongside a newly authorized $100M repurchase.

02

Market read

Maintained full-year guidance with quantified operating progress (remodel lift, table turns, delivery/catering growth) and a new buyback authorization can influence near-term sentiment and valuation support.

03

What to watch

Commodity cost assumptions (beef and contract lapping) and the pace of remodel closures could swing margins more than the reported KPI improvements if trends reverse in late Q3.

Relevance 7/10Novelty 6/10Timing: post-earnings call, published pre-market for Aug 7

Background

The piece summarizes Dine Brands’ Q2 2026 earnings call, focusing on consumer spending shifts, brand execution at Applebee’s and IHOP, and portfolio strategy.

Company-level read

Ticker impact

$DINBullishMedium confidence
Context

Dine Brands maintained full-year guidance while detailing Q2 operational momentum, remodel progress, and a new $100M buyback authorization.

Expected impact

Moderately positive bias for the next few sessions as traders price in maintained guidance and improving unit economics.

Evidence & confidence

The article is an earnings call summary with multiple concrete operating datapoints and a fresh capital return authorization, but it does not provide new consolidated financial figures beyond adjusted FCF and does not include a surprise guidance change.

Market effects

Reinforces the casual dining playbook of value-led traffic plus premium LTOs, with remodel and dual-brand conversions as key levers.

No specific regional impact disclosed beyond US domestic location targets.

Limited, as the story is US-focused restaurant operations and franchise conversions.

Counterpoint

Maintained guidance may already be priced in, and the adjusted free cash flow decline highlights near-term cash pressure from CapEx and marketing timing.

Key entities

  • Dine Brands Global, Inc.

    Owner and operator of Applebee’s and IHOP, providing Q2 execution updates, maintained full-year guidance, and a $100M share repurchase authorization.

  • Applebee’s

    Dine Brands’ value-plus-premium execution at the Applebee’s platform, including remodel program and delivery growth.

  • IHOP

    Dine Brands’ IHOP platform execution, including traffic outperformance, table-turn gains, and catering growth.

Related articles

$DINMed

Dine Brands (DIN) Q2 2026 Earnings Call Transcript

Dine Brands Global (DIN) reported Q2 2026 revenue of $240.9 million, up 4.4% year over year, driven mainly by acquiring restaurants from franchisees. Adjusted EBITDA fell to $54.2 million and adjusted diluted EPS was $1.16. IHOP domestic comps rose 1.5%, Applebee’s fell 1.8%. Management maintained full-year 2026 guidance.

$DINMed

Dine Brands Global, Inc. (DIN): Results of Operations and Financial Condition

Dine Brands Global, Inc. (DIN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d148591dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 News Release Investor Contact Matt Lee Sr. Vice President, Finance and Investor Relations Dine Brands Global, Inc. IR@dinebrands.com Media Contact Susan Nelson Sr. Vice President, Global Communications Dine Brands Global, I

$ORGOMed

Organogenesis (ORGO) Q2 2026 Earnings Call Transcript

Organogenesis (ORGO) reported Q2 2026 revenue down 58% year over year, driven by a 61% drop in Advanced Wound Care sales. Net product revenue rose 18% quarter over quarter. The company cited CMS coverage changes as slowing recovery, announced a June restructuring with 138 job cuts and about $18M annualized cost savings, and updated 2026 revenue guidance. It also cited DFU and venous ulcer study results and FDA acceptance of Amnuvx BLA with a PDUFA date of Apr 24, 2027.

$CRWVMed

CoreWeave Stock Buy or Sell Debate Intensifies in 2026 After Q2 Beat and $104 Billion Backlog

CoreWeave Inc. shares closed at $105.26 on Aug. 14, 2026 after its Q2 results. Revenue rose to $2.58B from $1.21B a year earlier; adjusted operating income was $128M, but GAAP net loss widened to $626M due to higher interest expense. The company raised 2026 revenue guidance to $12.4B-$13.2B and projected adjusted operating income of $960M-$1.15B. Backlog was about $104B.

$CELCMed

Celcuity Q2 Earnings Call Highlights

Celcuity (NASDAQ:CELC) reported Q2 earnings call highlights for its gedatolisib programs. In REVTORPYK, adverse-event discontinuations were 5.2% (mutant cohort) for the triplet and 3.8% for the doublet, versus 19% for alpelisib. The company is expanding VIKTORIA-2 and advancing a prostate Phase Ib/II trial with darolutamide. Q2 net loss was $78.9M ($1.44/share). Cash totaled $754M.